Allweiss L, Dandri M (2017) The role of cccDNA in HBV maintenance. Viruses 9:156. https://doi.org/10.3390/v9060156

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209–218. https://doi.org/10.1172/JCI24282

Bonacci M, Lens S, Mariño Z et al (2018) Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone. Aliment Pharmacol Ther 47:1397–1408. https://doi.org/10.1111/apt.14613

Article  CAS  PubMed  Google Scholar 

Butler EK, Gersch J, McNamara A et al (2018) Hepatitis B virus serum DNA and RNA levels in Nucleos(t)ide analog-treated or untreated patients during chronic and acute infection. Hepatology 68:2106–2117. https://doi.org/10.1002/hep.30082

Article  CAS  PubMed  Google Scholar 

Carey I, Gersch J, Wang B et al (2020) Pregenomic HBV RNA and hepatitis B core-related antigen predict outcomes in hepatitis B e antigen-negative chronic hepatitis B patients suppressed on nucleos(T)ide analogue therapy. Hepatology 72:42–57. https://doi.org/10.1002/hep.31026

Article  CAS  PubMed  Google Scholar 

Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical Association (2019) The guidelines of prevention and treatment for chronic hepatitis B (2019 version). Chin J Hepatol 35:2468–2669. https://doi.org/10.3760/cma.j.issn.1007-3418.2015.12.002

Article  CAS  Google Scholar 

Coffin CS, Zhou K, Terrault NA (2019) New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection. Gastroenterology 156:355-368.e3. https://doi.org/10.1053/j.gastro.2018.11.037

Article  CAS  PubMed  Google Scholar 

Fanning GC, Zoulim F, Hou J, Bertoletti A (2019) Therapeutic strategies for hepatitis B virus infection: towards a cure. Nat Rev Drug Discov 18:827–844. https://doi.org/10.1038/s41573-019-0037-0

Article  CAS  PubMed  Google Scholar 

Ghany MG, King WC, Lisker-Melman M et al (2021) Comparison of HBV RNA and hepatitis B core related antigen with conventional HBV markers among untreated adults with chronic hepatitis B in North America. Hepatology 74:2395–2409. https://doi.org/10.1002/hep.32018

Article  CAS  PubMed  Google Scholar 

Giersch K, Allweiss L, Volz T et al (2017) Serum HBV pgRNA as a clinical marker for cccDNA activity. J Hepatol 66:460–462. https://doi.org/10.1016/j.jhep.2016.09.028

Article  CAS  PubMed  Google Scholar 

Henderson NC, Rieder F, Wynn TA (2020) Fibrosis: from mechanisms to medicines. Nature 587:555–566. https://doi.org/10.1038/s41586-020-2938-9

Höner zu Siederdissen C, Maasoumy B, Cornberg M (2017) What is new on HBsAg and other diagnostic markers in HBV infection. Best Pract Res Clin Gastroenterol 31:281–289. https://doi.org/10.1016/j.bpg.2017.04.009

Article  CAS  PubMed  Google Scholar 

Huang H, Wang J, Li W et al (2018) Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals. J Clin Virol 99–100:71–78. https://doi.org/10.1016/j.jcv.2017.12.016

Article  CAS  PubMed  Google Scholar 

Huang C, Li Q, Xu W et al (2020) Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infection. Discov Med 29:119–128

CAS  PubMed  Google Scholar 

Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47:1363–1370. https://doi.org/10.1002/hep.22109

Article  CAS  PubMed  Google Scholar 

Köck J, Theilmann L, Galle P, Schlicht H (1996) Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus: hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 23:405–413. https://doi.org/10.1002/hep.510230303

Article  PubMed  Google Scholar 

Lai C-L, Wong D, Ip P et al (2017) Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B. J Hepatol 66:275–281. https://doi.org/10.1016/j.jhep.2016.08.022

Article  CAS  PubMed  Google Scholar 

Liao H, Li L, Zheng WV et al (2022) Characteristics of HBV novel serum markers across distinct phases in treatment-naïve chronic HBV-infected patients. Dis Markers 2022:1–13. https://doi.org/10.1155/2022/4133283

Article  CAS  Google Scholar 

Liu S, Zhou B, Valdes JD et al (2019) Serum hepatitis B virus RNA: a new potential biomarker for chronic hepatitis B virus infection. Hepatology 69:1816–1827. https://doi.org/10.1002/hep.30325

Article  PubMed  Google Scholar 

Liu S, Liu Z, Li W et al (2020) Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues. Aliment Pharmacol Ther 52:692–700. https://doi.org/10.1111/apt.15890

Article  CAS  PubMed  Google Scholar 

Lok ASF, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45:507–539. https://doi.org/10.1002/hep.21513

Article  CAS  PubMed  Google Scholar 

Mak L, Cloherty G, Wong DK et al (2021) HBV RNA profiles in patients with chronic hepatitis B under different disease phases and antiviral therapy. Hepatology 73:2167–2179. https://doi.org/10.1002/hep.31616

Article  CAS  PubMed  Google Scholar 

Nassal M (2015) HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 64:1972–1984. https://doi.org/10.1136/gutjnl-2015-309809

Article  CAS  PubMed  Google Scholar 

Nguyen MH, Wong G, Gane E et al (2020) Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev 33:e00046-e119. https://doi.org/10.1128/CMR.00046-19

Article  PubMed  PubMed Central  Google Scholar 

Ren S, Wang W, Lu J et al (2022) Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone. Front Immunol 13:1035923. https://doi.org/10.3389/fimmu.2022.1035923

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rockey DC, Caldwell SH, Goodman ZD et al (2009) Liver biopsy. Hepatology 49:1017–1044. https://doi.org/10.1002/hep.22742

Article  PubMed  Google Scholar 

Russo FP, Imondi A, Lynch EN, Farinati F (2018) When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. Dig Liver Dis 50:640–646. https://doi.org/10.1016/j.dld.2018.03.014

Article  PubMed  Google Scholar 

Schcuer J (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13:372–374. https://doi.org/10.1016/0168-8278(91)90084-o

Article  Google Scholar 

Shen S, Xie Z, Cai D et al (2020) Biogenesis and molecular characteristics of serum hepatitis B virus RNA. PLoS Pathog 16:e1008945. https://doi.org/10.1371/journal.ppat.1008945

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang LSY, Covert E, Wilson E, Kottilil S (2018) Chronic hepatitis B infection: a review. JAMA 319:1802. https://doi.org/10.1001/jama.2018.3795

Article  CAS  PubMed  Google Scholar 

Terrault NA, Bzowej NH, Chang K-M et al (2016) AASLD guidelines for treatment of chronic hepatitis B: hepatology, month 2015. Hepatology 63:261–283. https://doi.org/10.1002/hep.28156

Article  PubMed  Google Scholar 

Terrault N, Lok A, McMahon B et al (2018) Update on prevention, diagnosis, and treatment and of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67:1560–1599. https://doi.org/10.1002/hep.29800

Article  PubMed  Google Scholar 

Tsuge M, Murakami E, Imamura M et al (2013) Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients. J Gastroenterol 48:1188–1204. https://doi.org/10.1007/s00535-012-0737-2

Article  CAS  PubMed  Google Scholar 

van Bömmel F, van Bömmel A, Krauel A et al (2018) Serum HBV RNA as a predictor of peginterferon Alfa-2a response in patients with HBeAg-positive chronic hepatitis B. J Infect Dis 218:1066–1074. https://doi.org/10.1093/infdis/jiy270

Article  PubMed  Google Scholar 

Wang J, Yu Y, Li G et al (2018a) Natural history of serum HBV-RNA in chronic HBV infection. J Viral Hepat 25:1038–1047. https://doi.org/10.1111/jvh.12908

Article  CAS  PubMed  Google Scholar 

Wang J, Yu Y, Li G et al (2018b) Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients. J Hepatol 68:16–24. https://doi.org/10.1016/j.jhep.2017.08.021

Article  CAS  Google Scholar 

Wang X, Chi X, Wu R et al (2021) Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment. Virol J 18:4. https://doi.org/10.1186/s12985-020-01471-2

Article  CAS  PubMed